AtriCure (ATRC) Misses Q1 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.96 +1.92%
EPS Growth %: -300.0%
Financial Fact:
Gross profit: 27.47M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -300.0%
Financial Fact:
Gross profit: 27.47M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.25), $0.03 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $108.9 million versus the consensus estimate of $106.91 million.
GUIDANCE:
AtriCure sees FY2024 EPS of ($0.74)-($0.82), versus the consensus of ($0.76). AtriCure sees FY2024 revenue of $459-466 million, versus the consensus of $461.2 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Alcoa closes $2.6B debt offering to fund South32 asset acquisition
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
